RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American: TRXC) announced today that it plans to release fourth quarter and fiscal year 2017 financial and operating results after the market closes on Tuesday, March 6, 2018. Todd M. Pope, President and Chief Executive Officer, and Joseph P. Slattery, Executive Vice President and Chief Financial Officer will host a conference call to discuss these results starting at 4:30 pm Eastern Time the same day. The call will be concurrently webcast.
To listen to the conference call on your telephone, please dial (844) 804-5261 for domestic callers and (612) 979-9885 for international callers, and reference conference ID 7694988 approximately ten minutes prior to the start time. To access the live audio webcast or archived recording, use the following link http://ir.transenterix.com/events.cfm. The replay will be available on the Company's website.
About TransEnterix
TransEnterix is a medical device company
that is digitizing the interface between the surgeon and the patient to
improve minimally invasive surgery by addressing the clinical and
economic challenges associated with current laparoscopic and robotic
options in today's value-based healthcare environment. The Company is
focused on the commercialization of the Senhanceâ„¢ Surgical System, which
digitizes laparoscopic minimally invasive surgery. The system allows for
robotic precision, haptic feedback, surgeon camera control via eye
sensing and improved ergonomics while offering responsible economics.
The Senhance Surgical System is available for sale in the US, the EU and
select other countries. For more information, visit www.transenterix.com.